Table 3 Results of the HIFU trialsa

From: The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population

  

Intended area of ablation (cm2)

Measured area of ablation (cm2)

 

Ablation seen in

Median

Range

Median

Range

Liver

 Radiologically assessed

20/20 (100%)

4.8

0.8–9.0

3.3

0.1–42.9

 Histologically assessed

6/6 (100%)

5.5

3.8–7.5

5.6

0.2–16.0

Kidney

 Radiologically assessed

4/6 (67%)

4.0

1.5–6.0

5.3

0.8–9.7

 Histologically assessed

1/4 (25%)

4.5

4.8

  1. HIFU=high-intensity focused ultrasound.
  2. Comparison of the expected area of ablation at the time of treatment with that measured on follow-up imaging or histology.